A hallmark of The Scripps Research Institute (TSRI) is its interdisciplinary approach to scientific discovery, enabled by cross-cutting technologies. The institute's focus, broadly defined, is the quantitative molecular sciences and their connection to human health. TSRI is well positioned along the axis of translational science, the aim of which is to relate advances in the basic sciences to opportunities in drug discovery and disease-related research.
The scientific portfolio of the institute has three tiers: a foundation of activity in the basic molecular sciences; a middle layer of technology-driven discovery research involving either small molecule or macromolecular approaches; and a top layer of research that focuses on specific human diseases. TSRI is especially strong in the areas of immunology and infectious disease, biochemistry, structural biology, chemical biology, and organic chemistry. According to an analysis by Thompson Reuters Essential Science Indicators, the institute ranks first in the United States in citation impact in the chemical sciences during the past decade.
According to U.S. News & World Report’s periodic review of the nation’s graduate schools, TSRI’s Graduate Program ranks seventh in chemistry and ninth in biological sciences. The cutting edge of discovery is thrilling to the best scientists, and such individuals gravitate to TSRI, which counts among its faculty two Nobel Laureates and 17 members of the U.S. National Academy of Sciences.